Global Point of Care Technology
Global Point of Care Technology

Point of Care Technology Comprehensive Study by Type (Glucose Testing, Cardiac Markers, Hb1ac Testing, Coagulation), Testing types (Noninvasive (Infrared-based testing), Invasive(Microneedle devices), Multiplexing(Multiple detection zones, multiple labels, label-free), Continuous monitoring(Wearables, implantables, insertables)), End User (Hospitals, Home Care, Clinics, Ambulatory Care) Players and Region - Global Market Outlook to 2026

Point of Care Technology Market Segmented into XX Submarkets. | Forecast Years: 2021- 2026  

May 2021 Edition 248 Pages 172 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
What is Point of Care Technology Market Scope?
PoC technology includes devices and systems that aid healthcare professionals in their daily tasks of monitoring, caring for, and documenting patients' health progress. The fact that PoC technology is available at the bedside is the most important aspect. POC technologies are used to improve interactions between patients and their nurses, doctors, surgeons, and other medical advisors, resulting in better healthcare outcomes.

The Point of Care Technology market study is being classified by Type (Glucose Testing, Cardiac Markers, Hb1ac Testing and Coagulation) and major geographies with country level break-up.

The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Analysts at AMA predicts that Players from United States will contribute to the maximum growth of Global Point of Care Technology market throughout the predicted period.

Roche Diagnostics (Switzerland), Abbott Laboratories (United States), Siemens Healthineers (Germany), Becton, Dickinson and Company(United States), Johnson & Johnson (United States), Danaher Corporation (United States), Chembio Diagnostics (United States), Quidel Corporation(United States), EKF Diagnostics (United Kingdom) and Trinity Biotech (Ireland) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are AccuBioTech (China), Nova Biomedical (United States), PTS Diagnostics (United States), Instrumentation Laboratory Company (United States) and Sekisui Diagnostics (United States)..

Segmentation Analysis
Analyst at AMA have segmented the market study of Global Point of Care Technology market by Type, Application and Region.

On the basis of geography, the market of Point of Care Technology has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).

Market Influencers and their development strategies
Tulip Diagnostics to Acquire Biosense Technologies in India in November 2019 - Extends Capabilities in Point-of-Care Diagnostics Tulip is one of the country's largest domestic providers of in-vitro diagnostic reagents, kits, and instruments, with a diverse customer base that includes diagnostic laboratories, government and private healthcare facilities, and pharmaceutical companies.
Abbott, a company based in the United States, launched the ID NOW platforms in March 2020. The United States Food and Drug Administration (FDA) has granted an Emergency Use Authorization (EUA) for the fastest available molecular point-of-care test for the detection of novel coronavirus (COVID-19), which provides positive results in as little as five minutes and negative results in 13 minutes.


Influencing Market Trend
  • This review summarizes current and emerging trends in POCT, including technologies approved or cleared by the Food and Drug Administration or in development

Market Drivers
  • Pricing pressure owing to reimbursement cuts and budget constraints
  • Stringent regulatory policies

Opportunities
  • POC is increasingly important to population health, chronic disease, and to prevent acute admissions and readmissions
  • Increasing provider awareness about novel technologies

Restraints
  • Pricing pressure owing to reimbursement cuts and budget constraints
  • Stringent regulatory policies

Challenges
  • Premium pricing of novel platforms


Key Target Audience
New Entrants/Investors, Analysts and Strategic Business Planners, Point of Care Technology Provider, Government Regulatory and Research Organizations and End-Use Industry

Customization available in this Study:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.

To compete effectively, companies also require quantitative estimates of the future growth and qualitative nature of the market. AMA Research features not just specific market sizing estimates, but also include significant value-added commentary on Technological Trends and Innovations, Regulatory Policies, Market Maturity Indicators, Market Share Movements, New Entrants into the Market & Entry/Exit Barriers, Consumer Demographics, Supporting Company Financial and Cash Flow Planning, Open Up New Markets , To Seize Powerful Market Opportunities, Key Decision in Planning and to Further Expand Market Share, Identify Key Business Segments, Market Proposition & Gap Analysis.

Frequently Asked Questions (FAQ):

1. At what growth rate would the Point of Care Technology market expands?
The Global Point of Care Technology market is expected to see a growth of % during projected year 2020 to 2026.

2. Who are the prominent players of the Global Point of Care Technology market?
The prominent players of Global Point of Care Technology market are Roche Diagnostics (Switzerland), Abbott Laboratories (United States), Siemens Healthineers (Germany), Becton, Dickinson and Company(United States), Johnson & Johnson (United States), Danaher Corporation (United States), Chembio Diagnostics (United States), Quidel Corporation(United States), EKF Diagnostics (United Kingdom) and Trinity Biotech (Ireland), to name a few.

3. What are the top priorities to focus for Point of Care Technology marketís growth?
In this highly competitive & fast evolving Point of Care Technology industry, the top strategic priorities would remain consistent like innovation, R&D and M&A.
Report Objectives / Segmentation Covered
By Type
  • Glucose Testing
  • Cardiac Markers
  • Hb1ac Testing
  • Coagulation
By Application
By Testing types
  • Noninvasive (Infrared-based testing)
  • Invasive(Microneedle devices)
  • Multiplexing(Multiple detection zones, multiple labels, label-free)
  • Continuous monitoring(Wearables, implantables, insertables)

By End User
  • Hospitals
  • Home Care
  • Clinics
  • Ambulatory Care

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Pricing pressure owing to reimbursement cuts and budget constraints
      • 3.2.2. Stringent regulatory policies
    • 3.3. Market Challenges
      • 3.3.1. Premium pricing of novel platforms
    • 3.4. Market Trends
      • 3.4.1. This review summarizes current and emerging trends in POCT, including technologies approved or cleared by the Food and Drug Administration or in development
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Point of Care Technology, by Type, Testing types, End User and Region (value) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Point of Care Technology (Value)
      • 5.2.1. Global Point of Care Technology by: Type (Value)
        • 5.2.1.1. Glucose Testing
        • 5.2.1.2. Cardiac Markers
        • 5.2.1.3. Hb1ac Testing
        • 5.2.1.4. Coagulation
      • 5.2.2. Global Point of Care Technology by: Testing types (Value)
        • 5.2.2.1. Noninvasive (Infrared-based testing)
        • 5.2.2.2. Invasive(Microneedle devices)
        • 5.2.2.3. Multiplexing(Multiple detection zones, multiple labels, label-free)
        • 5.2.2.4. Continuous monitoring(Wearables, implantables, insertables)
      • 5.2.3. Global Point of Care Technology by: End User (Value)
        • 5.2.3.1. Hospitals
        • 5.2.3.2. Home Care
        • 5.2.3.3. Clinics
        • 5.2.3.4. Ambulatory Care
      • 5.2.4. Global Point of Care Technology Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
  • 6. Point of Care Technology: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Roche Diagnostics (Switzerland)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Abbott Laboratories (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Siemens Healthineers (Germany)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Becton, Dickinson and Company(United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Johnson & Johnson (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Danaher Corporation (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Chembio Diagnostics (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Quidel Corporation(United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. EKF Diagnostics (United Kingdom)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Trinity Biotech (Ireland)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Point of Care Technology Sale, by Type, Testing types, End User and Region (value) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Point of Care Technology (Value)
      • 7.2.1. Global Point of Care Technology by: Type (Value)
        • 7.2.1.1. Glucose Testing
        • 7.2.1.2. Cardiac Markers
        • 7.2.1.3. Hb1ac Testing
        • 7.2.1.4. Coagulation
      • 7.2.2. Global Point of Care Technology by: Testing types (Value)
        • 7.2.2.1. Noninvasive (Infrared-based testing)
        • 7.2.2.2. Invasive(Microneedle devices)
        • 7.2.2.3. Multiplexing(Multiple detection zones, multiple labels, label-free)
        • 7.2.2.4. Continuous monitoring(Wearables, implantables, insertables)
      • 7.2.3. Global Point of Care Technology by: End User (Value)
        • 7.2.3.1. Hospitals
        • 7.2.3.2. Home Care
        • 7.2.3.3. Clinics
        • 7.2.3.4. Ambulatory Care
      • 7.2.4. Global Point of Care Technology Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Point of Care Technology: by Type(USD Million)
  • Table 2. Point of Care Technology Glucose Testing , by Region USD Million (2015-2020)
  • Table 3. Point of Care Technology Cardiac Markers , by Region USD Million (2015-2020)
  • Table 4. Point of Care Technology Hb1ac Testing , by Region USD Million (2015-2020)
  • Table 5. Point of Care Technology Coagulation , by Region USD Million (2015-2020)
  • Table 6. Point of Care Technology: by Testing types(USD Million)
  • Table 7. Point of Care Technology Noninvasive (Infrared-based testing) , by Region USD Million (2015-2020)
  • Table 8. Point of Care Technology Invasive(Microneedle devices) , by Region USD Million (2015-2020)
  • Table 9. Point of Care Technology Multiplexing(Multiple detection zones, multiple labels, label-free) , by Region USD Million (2015-2020)
  • Table 10. Point of Care Technology Continuous monitoring(Wearables, implantables, insertables) , by Region USD Million (2015-2020)
  • Table 11. Point of Care Technology: by End User(USD Million)
  • Table 12. Point of Care Technology Hospitals , by Region USD Million (2015-2020)
  • Table 13. Point of Care Technology Home Care , by Region USD Million (2015-2020)
  • Table 14. Point of Care Technology Clinics , by Region USD Million (2015-2020)
  • Table 15. Point of Care Technology Ambulatory Care , by Region USD Million (2015-2020)
  • Table 16. South America Point of Care Technology, by Country USD Million (2015-2020)
  • Table 17. South America Point of Care Technology, by Type USD Million (2015-2020)
  • Table 18. South America Point of Care Technology, by Testing types USD Million (2015-2020)
  • Table 19. South America Point of Care Technology, by End User USD Million (2015-2020)
  • Table 20. Brazil Point of Care Technology, by Type USD Million (2015-2020)
  • Table 21. Brazil Point of Care Technology, by Testing types USD Million (2015-2020)
  • Table 22. Brazil Point of Care Technology, by End User USD Million (2015-2020)
  • Table 23. Argentina Point of Care Technology, by Type USD Million (2015-2020)
  • Table 24. Argentina Point of Care Technology, by Testing types USD Million (2015-2020)
  • Table 25. Argentina Point of Care Technology, by End User USD Million (2015-2020)
  • Table 26. Rest of South America Point of Care Technology, by Type USD Million (2015-2020)
  • Table 27. Rest of South America Point of Care Technology, by Testing types USD Million (2015-2020)
  • Table 28. Rest of South America Point of Care Technology, by End User USD Million (2015-2020)
  • Table 29. Asia Pacific Point of Care Technology, by Country USD Million (2015-2020)
  • Table 30. Asia Pacific Point of Care Technology, by Type USD Million (2015-2020)
  • Table 31. Asia Pacific Point of Care Technology, by Testing types USD Million (2015-2020)
  • Table 32. Asia Pacific Point of Care Technology, by End User USD Million (2015-2020)
  • Table 33. China Point of Care Technology, by Type USD Million (2015-2020)
  • Table 34. China Point of Care Technology, by Testing types USD Million (2015-2020)
  • Table 35. China Point of Care Technology, by End User USD Million (2015-2020)
  • Table 36. Japan Point of Care Technology, by Type USD Million (2015-2020)
  • Table 37. Japan Point of Care Technology, by Testing types USD Million (2015-2020)
  • Table 38. Japan Point of Care Technology, by End User USD Million (2015-2020)
  • Table 39. India Point of Care Technology, by Type USD Million (2015-2020)
  • Table 40. India Point of Care Technology, by Testing types USD Million (2015-2020)
  • Table 41. India Point of Care Technology, by End User USD Million (2015-2020)
  • Table 42. South Korea Point of Care Technology, by Type USD Million (2015-2020)
  • Table 43. South Korea Point of Care Technology, by Testing types USD Million (2015-2020)
  • Table 44. South Korea Point of Care Technology, by End User USD Million (2015-2020)
  • Table 45. Taiwan Point of Care Technology, by Type USD Million (2015-2020)
  • Table 46. Taiwan Point of Care Technology, by Testing types USD Million (2015-2020)
  • Table 47. Taiwan Point of Care Technology, by End User USD Million (2015-2020)
  • Table 48. Australia Point of Care Technology, by Type USD Million (2015-2020)
  • Table 49. Australia Point of Care Technology, by Testing types USD Million (2015-2020)
  • Table 50. Australia Point of Care Technology, by End User USD Million (2015-2020)
  • Table 51. Rest of Asia-Pacific Point of Care Technology, by Type USD Million (2015-2020)
  • Table 52. Rest of Asia-Pacific Point of Care Technology, by Testing types USD Million (2015-2020)
  • Table 53. Rest of Asia-Pacific Point of Care Technology, by End User USD Million (2015-2020)
  • Table 54. Europe Point of Care Technology, by Country USD Million (2015-2020)
  • Table 55. Europe Point of Care Technology, by Type USD Million (2015-2020)
  • Table 56. Europe Point of Care Technology, by Testing types USD Million (2015-2020)
  • Table 57. Europe Point of Care Technology, by End User USD Million (2015-2020)
  • Table 58. Germany Point of Care Technology, by Type USD Million (2015-2020)
  • Table 59. Germany Point of Care Technology, by Testing types USD Million (2015-2020)
  • Table 60. Germany Point of Care Technology, by End User USD Million (2015-2020)
  • Table 61. France Point of Care Technology, by Type USD Million (2015-2020)
  • Table 62. France Point of Care Technology, by Testing types USD Million (2015-2020)
  • Table 63. France Point of Care Technology, by End User USD Million (2015-2020)
  • Table 64. Italy Point of Care Technology, by Type USD Million (2015-2020)
  • Table 65. Italy Point of Care Technology, by Testing types USD Million (2015-2020)
  • Table 66. Italy Point of Care Technology, by End User USD Million (2015-2020)
  • Table 67. United Kingdom Point of Care Technology, by Type USD Million (2015-2020)
  • Table 68. United Kingdom Point of Care Technology, by Testing types USD Million (2015-2020)
  • Table 69. United Kingdom Point of Care Technology, by End User USD Million (2015-2020)
  • Table 70. Netherlands Point of Care Technology, by Type USD Million (2015-2020)
  • Table 71. Netherlands Point of Care Technology, by Testing types USD Million (2015-2020)
  • Table 72. Netherlands Point of Care Technology, by End User USD Million (2015-2020)
  • Table 73. Rest of Europe Point of Care Technology, by Type USD Million (2015-2020)
  • Table 74. Rest of Europe Point of Care Technology, by Testing types USD Million (2015-2020)
  • Table 75. Rest of Europe Point of Care Technology, by End User USD Million (2015-2020)
  • Table 76. MEA Point of Care Technology, by Country USD Million (2015-2020)
  • Table 77. MEA Point of Care Technology, by Type USD Million (2015-2020)
  • Table 78. MEA Point of Care Technology, by Testing types USD Million (2015-2020)
  • Table 79. MEA Point of Care Technology, by End User USD Million (2015-2020)
  • Table 80. Middle East Point of Care Technology, by Type USD Million (2015-2020)
  • Table 81. Middle East Point of Care Technology, by Testing types USD Million (2015-2020)
  • Table 82. Middle East Point of Care Technology, by End User USD Million (2015-2020)
  • Table 83. Africa Point of Care Technology, by Type USD Million (2015-2020)
  • Table 84. Africa Point of Care Technology, by Testing types USD Million (2015-2020)
  • Table 85. Africa Point of Care Technology, by End User USD Million (2015-2020)
  • Table 86. North America Point of Care Technology, by Country USD Million (2015-2020)
  • Table 87. North America Point of Care Technology, by Type USD Million (2015-2020)
  • Table 88. North America Point of Care Technology, by Testing types USD Million (2015-2020)
  • Table 89. North America Point of Care Technology, by End User USD Million (2015-2020)
  • Table 90. United States Point of Care Technology, by Type USD Million (2015-2020)
  • Table 91. United States Point of Care Technology, by Testing types USD Million (2015-2020)
  • Table 92. United States Point of Care Technology, by End User USD Million (2015-2020)
  • Table 93. Canada Point of Care Technology, by Type USD Million (2015-2020)
  • Table 94. Canada Point of Care Technology, by Testing types USD Million (2015-2020)
  • Table 95. Canada Point of Care Technology, by End User USD Million (2015-2020)
  • Table 96. Mexico Point of Care Technology, by Type USD Million (2015-2020)
  • Table 97. Mexico Point of Care Technology, by Testing types USD Million (2015-2020)
  • Table 98. Mexico Point of Care Technology, by End User USD Million (2015-2020)
  • Table 99. Company Basic Information, Sales Area and Its Competitors
  • Table 100. Company Basic Information, Sales Area and Its Competitors
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Company Basic Information, Sales Area and Its Competitors
  • Table 107. Company Basic Information, Sales Area and Its Competitors
  • Table 108. Company Basic Information, Sales Area and Its Competitors
  • Table 109. Point of Care Technology: by Type(USD Million)
  • Table 110. Point of Care Technology Glucose Testing , by Region USD Million (2021-2026)
  • Table 111. Point of Care Technology Cardiac Markers , by Region USD Million (2021-2026)
  • Table 112. Point of Care Technology Hb1ac Testing , by Region USD Million (2021-2026)
  • Table 113. Point of Care Technology Coagulation , by Region USD Million (2021-2026)
  • Table 114. Point of Care Technology: by Testing types(USD Million)
  • Table 115. Point of Care Technology Noninvasive (Infrared-based testing) , by Region USD Million (2021-2026)
  • Table 116. Point of Care Technology Invasive(Microneedle devices) , by Region USD Million (2021-2026)
  • Table 117. Point of Care Technology Multiplexing(Multiple detection zones, multiple labels, label-free) , by Region USD Million (2021-2026)
  • Table 118. Point of Care Technology Continuous monitoring(Wearables, implantables, insertables) , by Region USD Million (2021-2026)
  • Table 119. Point of Care Technology: by End User(USD Million)
  • Table 120. Point of Care Technology Hospitals , by Region USD Million (2021-2026)
  • Table 121. Point of Care Technology Home Care , by Region USD Million (2021-2026)
  • Table 122. Point of Care Technology Clinics , by Region USD Million (2021-2026)
  • Table 123. Point of Care Technology Ambulatory Care , by Region USD Million (2021-2026)
  • Table 124. South America Point of Care Technology, by Country USD Million (2021-2026)
  • Table 125. South America Point of Care Technology, by Type USD Million (2021-2026)
  • Table 126. South America Point of Care Technology, by Testing types USD Million (2021-2026)
  • Table 127. South America Point of Care Technology, by End User USD Million (2021-2026)
  • Table 128. Brazil Point of Care Technology, by Type USD Million (2021-2026)
  • Table 129. Brazil Point of Care Technology, by Testing types USD Million (2021-2026)
  • Table 130. Brazil Point of Care Technology, by End User USD Million (2021-2026)
  • Table 131. Argentina Point of Care Technology, by Type USD Million (2021-2026)
  • Table 132. Argentina Point of Care Technology, by Testing types USD Million (2021-2026)
  • Table 133. Argentina Point of Care Technology, by End User USD Million (2021-2026)
  • Table 134. Rest of South America Point of Care Technology, by Type USD Million (2021-2026)
  • Table 135. Rest of South America Point of Care Technology, by Testing types USD Million (2021-2026)
  • Table 136. Rest of South America Point of Care Technology, by End User USD Million (2021-2026)
  • Table 137. Asia Pacific Point of Care Technology, by Country USD Million (2021-2026)
  • Table 138. Asia Pacific Point of Care Technology, by Type USD Million (2021-2026)
  • Table 139. Asia Pacific Point of Care Technology, by Testing types USD Million (2021-2026)
  • Table 140. Asia Pacific Point of Care Technology, by End User USD Million (2021-2026)
  • Table 141. China Point of Care Technology, by Type USD Million (2021-2026)
  • Table 142. China Point of Care Technology, by Testing types USD Million (2021-2026)
  • Table 143. China Point of Care Technology, by End User USD Million (2021-2026)
  • Table 144. Japan Point of Care Technology, by Type USD Million (2021-2026)
  • Table 145. Japan Point of Care Technology, by Testing types USD Million (2021-2026)
  • Table 146. Japan Point of Care Technology, by End User USD Million (2021-2026)
  • Table 147. India Point of Care Technology, by Type USD Million (2021-2026)
  • Table 148. India Point of Care Technology, by Testing types USD Million (2021-2026)
  • Table 149. India Point of Care Technology, by End User USD Million (2021-2026)
  • Table 150. South Korea Point of Care Technology, by Type USD Million (2021-2026)
  • Table 151. South Korea Point of Care Technology, by Testing types USD Million (2021-2026)
  • Table 152. South Korea Point of Care Technology, by End User USD Million (2021-2026)
  • Table 153. Taiwan Point of Care Technology, by Type USD Million (2021-2026)
  • Table 154. Taiwan Point of Care Technology, by Testing types USD Million (2021-2026)
  • Table 155. Taiwan Point of Care Technology, by End User USD Million (2021-2026)
  • Table 156. Australia Point of Care Technology, by Type USD Million (2021-2026)
  • Table 157. Australia Point of Care Technology, by Testing types USD Million (2021-2026)
  • Table 158. Australia Point of Care Technology, by End User USD Million (2021-2026)
  • Table 159. Rest of Asia-Pacific Point of Care Technology, by Type USD Million (2021-2026)
  • Table 160. Rest of Asia-Pacific Point of Care Technology, by Testing types USD Million (2021-2026)
  • Table 161. Rest of Asia-Pacific Point of Care Technology, by End User USD Million (2021-2026)
  • Table 162. Europe Point of Care Technology, by Country USD Million (2021-2026)
  • Table 163. Europe Point of Care Technology, by Type USD Million (2021-2026)
  • Table 164. Europe Point of Care Technology, by Testing types USD Million (2021-2026)
  • Table 165. Europe Point of Care Technology, by End User USD Million (2021-2026)
  • Table 166. Germany Point of Care Technology, by Type USD Million (2021-2026)
  • Table 167. Germany Point of Care Technology, by Testing types USD Million (2021-2026)
  • Table 168. Germany Point of Care Technology, by End User USD Million (2021-2026)
  • Table 169. France Point of Care Technology, by Type USD Million (2021-2026)
  • Table 170. France Point of Care Technology, by Testing types USD Million (2021-2026)
  • Table 171. France Point of Care Technology, by End User USD Million (2021-2026)
  • Table 172. Italy Point of Care Technology, by Type USD Million (2021-2026)
  • Table 173. Italy Point of Care Technology, by Testing types USD Million (2021-2026)
  • Table 174. Italy Point of Care Technology, by End User USD Million (2021-2026)
  • Table 175. United Kingdom Point of Care Technology, by Type USD Million (2021-2026)
  • Table 176. United Kingdom Point of Care Technology, by Testing types USD Million (2021-2026)
  • Table 177. United Kingdom Point of Care Technology, by End User USD Million (2021-2026)
  • Table 178. Netherlands Point of Care Technology, by Type USD Million (2021-2026)
  • Table 179. Netherlands Point of Care Technology, by Testing types USD Million (2021-2026)
  • Table 180. Netherlands Point of Care Technology, by End User USD Million (2021-2026)
  • Table 181. Rest of Europe Point of Care Technology, by Type USD Million (2021-2026)
  • Table 182. Rest of Europe Point of Care Technology, by Testing types USD Million (2021-2026)
  • Table 183. Rest of Europe Point of Care Technology, by End User USD Million (2021-2026)
  • Table 184. MEA Point of Care Technology, by Country USD Million (2021-2026)
  • Table 185. MEA Point of Care Technology, by Type USD Million (2021-2026)
  • Table 186. MEA Point of Care Technology, by Testing types USD Million (2021-2026)
  • Table 187. MEA Point of Care Technology, by End User USD Million (2021-2026)
  • Table 188. Middle East Point of Care Technology, by Type USD Million (2021-2026)
  • Table 189. Middle East Point of Care Technology, by Testing types USD Million (2021-2026)
  • Table 190. Middle East Point of Care Technology, by End User USD Million (2021-2026)
  • Table 191. Africa Point of Care Technology, by Type USD Million (2021-2026)
  • Table 192. Africa Point of Care Technology, by Testing types USD Million (2021-2026)
  • Table 193. Africa Point of Care Technology, by End User USD Million (2021-2026)
  • Table 194. North America Point of Care Technology, by Country USD Million (2021-2026)
  • Table 195. North America Point of Care Technology, by Type USD Million (2021-2026)
  • Table 196. North America Point of Care Technology, by Testing types USD Million (2021-2026)
  • Table 197. North America Point of Care Technology, by End User USD Million (2021-2026)
  • Table 198. United States Point of Care Technology, by Type USD Million (2021-2026)
  • Table 199. United States Point of Care Technology, by Testing types USD Million (2021-2026)
  • Table 200. United States Point of Care Technology, by End User USD Million (2021-2026)
  • Table 201. Canada Point of Care Technology, by Type USD Million (2021-2026)
  • Table 202. Canada Point of Care Technology, by Testing types USD Million (2021-2026)
  • Table 203. Canada Point of Care Technology, by End User USD Million (2021-2026)
  • Table 204. Mexico Point of Care Technology, by Type USD Million (2021-2026)
  • Table 205. Mexico Point of Care Technology, by Testing types USD Million (2021-2026)
  • Table 206. Mexico Point of Care Technology, by End User USD Million (2021-2026)
  • Table 207. Research Programs/Design for This Report
  • Table 208. Key Data Information from Secondary Sources
  • Table 209. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Point of Care Technology: by Type USD Million (2015-2020)
  • Figure 5. Global Point of Care Technology: by Testing types USD Million (2015-2020)
  • Figure 6. Global Point of Care Technology: by End User USD Million (2015-2020)
  • Figure 7. South America Point of Care Technology Share (%), by Country
  • Figure 8. Asia Pacific Point of Care Technology Share (%), by Country
  • Figure 9. Europe Point of Care Technology Share (%), by Country
  • Figure 10. MEA Point of Care Technology Share (%), by Country
  • Figure 11. North America Point of Care Technology Share (%), by Country
  • Figure 12. Global Point of Care Technology share by Players 2020 (%)
  • Figure 13. Global Point of Care Technology share by Players (Top 3) 2020(%)
  • Figure 14. Global Point of Care Technology share by Players (Top 5) 2020(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. Roche Diagnostics (Switzerland) Revenue, Net Income and Gross profit
  • Figure 17. Roche Diagnostics (Switzerland) Revenue: by Geography 2020
  • Figure 18. Abbott Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 19. Abbott Laboratories (United States) Revenue: by Geography 2020
  • Figure 20. Siemens Healthineers (Germany) Revenue, Net Income and Gross profit
  • Figure 21. Siemens Healthineers (Germany) Revenue: by Geography 2020
  • Figure 22. Becton, Dickinson and Company(United States) Revenue, Net Income and Gross profit
  • Figure 23. Becton, Dickinson and Company(United States) Revenue: by Geography 2020
  • Figure 24. Johnson & Johnson (United States) Revenue, Net Income and Gross profit
  • Figure 25. Johnson & Johnson (United States) Revenue: by Geography 2020
  • Figure 26. Danaher Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 27. Danaher Corporation (United States) Revenue: by Geography 2020
  • Figure 28. Chembio Diagnostics (United States) Revenue, Net Income and Gross profit
  • Figure 29. Chembio Diagnostics (United States) Revenue: by Geography 2020
  • Figure 30. Quidel Corporation(United States) Revenue, Net Income and Gross profit
  • Figure 31. Quidel Corporation(United States) Revenue: by Geography 2020
  • Figure 32. EKF Diagnostics (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 33. EKF Diagnostics (United Kingdom) Revenue: by Geography 2020
  • Figure 34. Trinity Biotech (Ireland) Revenue, Net Income and Gross profit
  • Figure 35. Trinity Biotech (Ireland) Revenue: by Geography 2020
  • Figure 36. Global Point of Care Technology: by Type USD Million (2021-2026)
  • Figure 37. Global Point of Care Technology: by Testing types USD Million (2021-2026)
  • Figure 38. Global Point of Care Technology: by End User USD Million (2021-2026)
  • Figure 39. South America Point of Care Technology Share (%), by Country
  • Figure 40. Asia Pacific Point of Care Technology Share (%), by Country
  • Figure 41. Europe Point of Care Technology Share (%), by Country
  • Figure 42. MEA Point of Care Technology Share (%), by Country
  • Figure 43. North America Point of Care Technology Share (%), by Country
Some of the key companies/manufacturers profiled in the report
  • Roche Diagnostics (Switzerland)
  • Abbott Laboratories (United States)
  • Siemens Healthineers (Germany)
  • Becton, Dickinson and Company(United States)
  • Johnson & Johnson (United States)
  • Danaher Corporation (United States)
  • Chembio Diagnostics (United States)
  • Quidel Corporation(United States)
  • EKF Diagnostics (United Kingdom)
  • Trinity Biotech (Ireland)
Additional players considered in the study are as follows:
AccuBioTech (China) , Nova Biomedical (United States) , PTS Diagnostics (United States) , Instrumentation Laboratory Company (United States) , Sekisui Diagnostics (United States).
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation